Mangalam Drugs Compliance Officer Resignation

Mangalam Drugs files revised SEBI disclosure announcing resignation of Company Secretary & Compliance Officer Anuradha Pandey effective March 29, 2026.
Resignation was submitted due to Pandey's decision to pursue opportunities outside the company, as stated in her January 2 letter.
Company acknowledges filing delay was caused by inadvertent administrative oversight in tracking disclosure timeline.
Disclosure includes detailed resignation reasons and compliance with SEBI Circulars CIR/CFD/CMD/4/2015 and SEBI/HO/CFD/PoD2/CIR/P/0155.